Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,068 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not Matter.
Kamat AM, Lobo N, Lerner SP, Li R, Matulay JT, Palou J, Witjes JA, Rouprêt M, Smith AB, Chang SS, Shore ND, Steinberg GD, Dinney CP, Svatek RS, Lamm DL. Kamat AM, et al. Among authors: roupret m. Bladder Cancer. 2022 Jun 3;8(2):113-117. doi: 10.3233/BLC-211648. eCollection 2022. Bladder Cancer. 2022. PMID: 38993360 Free PMC article.
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG).
Contieri R, Soloway MS, Gontero P, Herr H, Kassouf W, Mertens LS, Moschini M, O'Donnell M, Palou J, Psutka SP, Rouprêt M, Teoh JYC, Kamat AM. Contieri R, et al. Among authors: roupret m. Eur Urol Oncol. 2024 Aug 31:S2588-9311(24)00186-X. doi: 10.1016/j.euo.2024.08.001. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39218742 Review.
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.
Catto JWF, Tran B, Rouprêt M, Gschwend JE, Loriot Y, Nishiyama H, Redorta JP, Daneshmand S, Hussain SA, Cutuli HJ, Procopio G, Guadalupi V, Vasdev N, Naini V, Crow L, Triantos S, Baig M, Steinberg G; THOR-2 Cohort 1 Investigators. Catto JWF, et al. Among authors: roupret m. Ann Oncol. 2024 Jan;35(1):98-106. doi: 10.1016/j.annonc.2023.09.3116. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871701 Free article. Clinical Trial.
Radiotherapy Combined with a Radiosensitizer for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Carcinoma In Situ Bladder Cancer: An Open-label, Single-arm, Multicenter, Phase 2 European Organisation for Research and Treatment of Cancer Trial.
Achard V, Fournier B, D'Haese D, Krzystyniak J, Tombal B, Roupret M, Sargos P, Dirix P. Achard V, et al. Among authors: roupret m. Eur Urol Oncol. 2024 Oct;7(5):982-985. doi: 10.1016/j.euo.2024.03.008. Epub 2024 Mar 30. Eur Urol Oncol. 2024. PMID: 38556413 Clinical Trial.
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancer.
Laukhtina E, Gontero P, Babjuk M, Moschini M, Teoh JY, Rouprêt M, Trinh QD, Chlosta P, Nyirády P, Abufaraj M, Soria F, Klemm J, Bekku K, Matsukawa A, Shariat SF. Laukhtina E, et al. Among authors: roupret m. BJU Int. 2024 Oct;134(4):644-651. doi: 10.1111/bju.16371. Epub 2024 Apr 16. BJU Int. 2024. PMID: 38627025
1,068 results